{"data": [{"news_url": "https://seekingalpha.com/article/4388195-moderna-inc-mrna-ceo-stephane-bancel-presents-credit-suisse-29th-annual-virtual-healthcare", "image_url": "https://cdn.snapi.dev/images/v1/q/g/transcript50.jpg", "title": "Moderna, Inc. (MRNA) CEO St\u00e9phane Bancel Presents at Credit Suisse 29th Annual Virtual Healthcare Conference (Transcript)", "text": "Moderna, Inc. (MRNA) CEO St\u00e9phane Bancel Presents at Credit Suisse 29th Annual Virtual Healthcare Conference (Transcript)", "source_name": "Seeking Alpha", "date": "Wed, 11 Nov 2020 17:29:06 -0500", "topics": ["CallScript", "CEO"], "sentiment": "Neutral", "type": "Article", "tickers": ["MRNA"]}, {"news_url": "https://www.marketwatch.com/story/moderna-stock-ticks-higher-as-first-set-of-covid-19-vaccine-data-is-ready-for-analysis-11605131994", "image_url": "https://cdn.snapi.dev/images/v1/e/9/tgfre4323.jpg", "title": "Moderna stock ticks higher as first set of COVID-19 vaccine data is ready for analysis", "text": "Moderna Inc. MRNA shares ticked higher in the extended session Wednesday after the biotech company said the first batch of data from its late-stage test of an experimental COVID-19 vaccine was ready for analysis. Moderna shares rose 1% after hours, following an 8.4% rise to close the regular session at $82.44.", "source_name": "Market Watch", "date": "Wed, 11 Nov 2020 16:59:00 -0500", "topics": ["paywall"], "sentiment": "Positive", "type": "Article", "tickers": ["MRNA"]}, {"news_url": "https://www.youtube.com/watch?v=fc4B45FXZd0", "image_url": "https://cdn.snapi.dev/images/v1/t/h/moderna-says-company-has-enough-cases-to-provide-analysis-on-its-covid-19-vaccine-trial.jpg", "title": "Moderna says company has enough cases to provide analysis on its Covid-19 vaccine trial", "text": "CNBC's Meg Tirrell says Moderna announced it has enough cases to determine if its vaccine works. She joins 'Closing Bell' to discuss.", "source_name": "CNBC Television", "date": "Wed, 11 Nov 2020 16:35:02 -0500", "topics": [], "sentiment": "Positive", "type": "Video", "tickers": ["MRNA"]}, {"news_url": "https://www.businesswire.com/news/home/20201111005805/en/Moderna-Has-Completed-Case-Accrual-for-First-Planned-Interim-Analysis-of-its-mRNA-Vaccine-Against-COVID-19-mRNA-1273/", "image_url": "https://cdn.snapi.dev/images/v1/p/r/press13---thdabw1b4e.jpg", "title": "Moderna Has Completed Case Accrual for First Planned Interim Analysis of its mRNA Vaccine Against COVID-19 (mRNA-1273)", "text": "CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna has completed case accrual for first planned interim analysis of its mRNA vaccine against COVID-19 (mRNA-1273).", "source_name": "Business Wire", "date": "Wed, 11 Nov 2020 16:01:00 -0500", "topics": ["PressRelease"], "sentiment": "Neutral", "type": "Article", "tickers": ["MRNA"]}, {"news_url": "https://www.fool.com/investing/2020/11/11/why-moderna-stock-vaulted-higher-today/", "image_url": "https://cdn.snapi.dev/images/v1/q/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6004402fscientist-looking-through-microscope-brain-imagesjpgw700opresize.jpg", "title": "Why Moderna Stock Vaulted Higher Today", "text": "Hint: It had nothing to do with the biotech's coronavirus vaccine candidate.", "source_name": "The Motley Fool", "date": "Wed, 11 Nov 2020 15:40:03 -0500", "topics": [], "sentiment": "Positive", "type": "Article", "tickers": ["MRNA"]}, {"news_url": "https://www.fool.com/investing/2020/11/11/modernas-cancer-vaccine-scores-in-a-clinical-trial/", "image_url": "https://cdn.snapi.dev/images/v1/v/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6003732fguy-in-a-labcoat-pipeting-purple-stuff-into-flask-gettyjpgw700opresize.jpg", "title": "Moderna's Cancer Vaccine Scores in a Clinical Trial", "text": "Early-stage clinical trial results suggest adding mRNA-4157 to Keytruda can improve response rates.", "source_name": "The Motley Fool", "date": "Wed, 11 Nov 2020 15:15:00 -0500", "topics": [], "sentiment": "Positive", "type": "Article", "tickers": ["MRNA"]}, {"news_url": "https://www.investors.com/news/technology/moderna-stock-pops-anthony-fauci-predicts-coronavirus-vaccine-effective-pfizer/", "image_url": "https://cdn.snapi.dev/images/v1/w/w/biotech39.jpg", "title": "Moderna Pops After Fauci Predicts Its Vaccine Will Be As Effective As Pfizer's", "text": "Moderna popped Wednesday after Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, predicted its coronavirus vaccine would be as effective as Pfizer's. The post Moderna Pops After Fauci Predicts Its Vaccine Will Be As Effective As Pfizer's appeared first on Investor's Business Daily.", "source_name": "Investors Business Daily", "date": "Wed, 11 Nov 2020 14:08:59 -0500", "topics": [], "sentiment": "Positive", "type": "Article", "tickers": ["MRNA"]}, {"news_url": "https://www.forbes.com/sites/greatspeculations/2020/11/11/pfizers-covid-19-success-bodes-very-well-for-moderna/", "image_url": "https://cdn.snapi.dev/images/v1/m/f/pfizers-covid-19-success-bodes-very-well-for-moderna.jpg", "title": "Pfizer's Covid-19 Success Bodes Very Well For Moderna", "text": "While Pfizer\u2018s surprisingly strong initial Covid-19 vaccine efficacy readout likely marks the beginning of the end of the Covid-19 pandemic, it probably doesn't mean too much for Pfizer stock, given the limited potential profits and challenges with distribution. In fact, we think that the strong.", "source_name": "Forbes", "date": "Wed, 11 Nov 2020 11:00:00 -0500", "topics": [], "sentiment": "Positive", "type": "Article", "tickers": ["MRNA"]}, {"news_url": "https://www.zacks.com/stock/news/1100121/vaccine-hopes-rise-as-pharma-giants-inch-closer-toward-success", "image_url": "https://cdn.snapi.dev/images/v1/a/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5916012fhypodermic-needles-syringe-drug-pharmajpgw700opresize.jpg", "title": "Vaccine Hopes Rise as Pharma Giants Inch Closer Toward Success", "text": "Stocks of Eli Lilly and Company (LLY), Pfizer, Inc. (PFE) and Moderna, Inc. (MRNA) have been in focus since the coronavirus outbreak as they have been the frontrunners in the vaccine race.", "source_name": "Zacks Investment Research", "date": "Wed, 11 Nov 2020 08:40:00 -0500", "topics": [], "sentiment": "Positive", "type": "Article", "tickers": ["AZN", "BNTX", "GILD", "LLY", "MRNA", "PFE"]}, {"news_url": "https://www.businesswire.com/news/home/20201111005423/en/Moderna-Announces-Clinical-Updates-on-Personalized-Cancer-Vaccine-Program/", "image_url": "https://cdn.snapi.dev/images/v1/p/r/press3---oqhhrmm5po.jpg", "title": "Moderna Announces Clinical Updates on Personalized Cancer Vaccine Program", "text": "CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna announces clinical updates on Personalized Cancer Vaccine program", "source_name": "Business Wire", "date": "Wed, 11 Nov 2020 07:09:00 -0500", "topics": ["PressRelease"], "sentiment": "Neutral", "type": "Article", "tickers": ["MRNA"]}, {"news_url": "https://www.fool.com/investing/2020/11/11/5-reasons-chasing-covid-19-vaccine-stocks-is-a-bad/", "image_url": "https://cdn.snapi.dev/images/v1/w/o/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6000002fdoctor-giving-vaccine-flu-shot-to-senior-gettyjpgw700opresize.jpg", "title": "5 Reasons Chasing COVID-19 Vaccine Stocks Is a Bad Idea", "text": "Investors are setting themselves up for disappointment.", "source_name": "The Motley Fool", "date": "Wed, 11 Nov 2020 06:06:00 -0500", "topics": [], "sentiment": "Negative", "type": "Article", "tickers": ["AZN", "INO", "JNJ", "MRNA", "PFE", "BNTX"]}]}